🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
316,13 USD
Máx. histórico
322,75
5 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,05%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+0,83%
Cierre anterior
313,52
Rango de hoy
309,86 – 319,18
Volumen hoy
179.912
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 124,46 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 22 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 10/06/1996 | 64,57 | 64,57 | 61,76 | 64,10 | -0,72% | 4,35% | 20.171 |
| 07/06/1996 | 58,95 | 65,50 | 58,02 | 64,57 | +3,76% | 12,70% | 68.795 |
| 06/06/1996 | 64,10 | 64,10 | 61,29 | 62,23 | -2,92% | 4,38% | 13.706 |
| 05/06/1996 | 63,16 | 64,10 | 61,29 | 64,10 | +1,48% | 4,44% | 28.694 |
| 04/06/1996 | 62,23 | 63,16 | 61,29 | 63,16 | +1,50% | 3,01% | 29.362 |
| 03/06/1996 | 61,76 | 62,69 | 61,29 | 62,23 | -0,75% | 2,27% | 47.315 |
| 31/05/1996 | 64,57 | 64,57 | 61,76 | 62,69 | -2,90% | 4,35% | 51.964 |
| 30/05/1996 | 63,63 | 64,57 | 62,23 | 64,57 | +2,22% | 3,68% | 78.440 |
| 29/05/1996 | 73,92 | 73,92 | 61,76 | 63,16 | -11,18% | 16,46% | 163.853 |
| 28/05/1996 | 61,76 | 71,58 | 61,76 | 71,12 | +18,75% | 15,91% | 208.898 |
| 24/05/1996 | 60,82 | 60,82 | 58,95 | 59,89 | +0,79% | 3,08% | 19.209 |
| 23/05/1996 | 59,89 | 60,82 | 58,48 | 59,42 | +0,00% | 3,91% | 32.915 |
| 22/05/1996 | 60,82 | 62,23 | 58,95 | 59,42 | -3,05% | 5,38% | 27.785 |
| 21/05/1996 | 60,36 | 62,69 | 58,95 | 61,29 | +3,97% | 6,20% | 58.189 |
| 20/05/1996 | 58,95 | 59,89 | 58,02 | 58,95 | +0,80% | 3,17% | 45.071 |
| 17/05/1996 | 58,02 | 59,89 | 58,02 | 58,48 | +0,40% | 3,23% | 74.646 |
| 16/05/1996 | 59,89 | 59,89 | 58,02 | 58,25 | -1,19% | 3,13% | 31.552 |
| 15/05/1996 | 60,82 | 60,82 | 58,72 | 58,95 | +0,00% | 3,46% | 26.209 |
| 14/05/1996 | 58,95 | 61,29 | 57,08 | 58,95 | +0,80% | 7,14% | 42.105 |
| 13/05/1996 | 56,61 | 58,95 | 56,61 | 58,48 | +0,81% | 4,13% | 31.205 |
| 10/05/1996 | 57,08 | 58,02 | 56,14 | 58,02 | +1,64% | 3,28% | 32.568 |
| 09/05/1996 | 56,14 | 57,08 | 55,21 | 57,08 | +3,39% | 3,33% | 55.758 |
| 08/05/1996 | 58,02 | 58,02 | 55,21 | 55,21 | -4,84% | 4,84% | 54.823 |
| 07/05/1996 | 58,02 | 59,42 | 57,08 | 58,02 | +0,00% | 4,03% | 123.030 |
| 06/05/1996 | 55,68 | 58,02 | 54,74 | 58,02 | +5,98% | 5,88% | 59.391 |
| 03/05/1996 | 55,21 | 55,68 | 54,74 | 54,74 | +1,74% | 1,70% | 29.014 |
| 02/05/1996 | 55,21 | 57,08 | 53,81 | 53,81 | -4,17% | 5,93% | 62.998 |
| 01/05/1996 | 56,14 | 56,61 | 54,74 | 56,14 | +2,56% | 3,33% | 31.739 |
| 30/04/1996 | 57,08 | 57,08 | 54,74 | 54,74 | -1,68% | 4,10% | 30.430 |
| 29/04/1996 | 56,14 | 58,95 | 54,27 | 55,68 | +0,00% | 8,33% | 131.713 |